Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof

MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof

US Patent 12029782 · Granted Jul 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hinge-link spinal correction device and method2025
External fixation strut2025
Multimeric T-cell modulatory polypeptides and methods of use thereof2025
Multimeric T-cell modulatory polypeptides and methods of use thereof2025
Multimeric T-cell modulatory polypeptides and methods of use thereof2025
Multimeric T-cell modulatory polypeptides and methods of use thereof2025
T-cell modulatory multimeric polypeptides and methods of use thereof2025
T-cell modulatory multimeric polypeptides and methods of use thereof2025
Multimeric T-cell modulatory polypeptides and methods of use thereof2025
Multimeric T-cell modulatory polypeptides and methods of use thereof2025
Multimeric T-cell modulatory polypeptides and methods of use thereof2025
T-cell modulatory multimeric polypeptides and methods of use thereof2024